René Botnar received his PhD in Biomedical Engineering from the ETH Zurich. In 1997, he joined the Cardiac MR Center at the Beth Israel Deaconess Medical Center and Harvard Medical School where his research focus was on the development and clinical validation of novel MRI sequences and molecular contrast agents for the non-invasive detection of coronary artery disease.
In 2003, Dr. Botnar became the Scientific Director of the Cardiac MR Center at the Beth Israel Deaconess Medical Center and was appointed Assistant Professor of Medicine at Harvard Medical School, Boston, USA. In 2005, Dr. Botnar accepted a Professorship of Biomedical Imaging at TUM and at the end of 2007, he joined King’s College London where he is Professor of Cardiovascular Imaging and where he set up a cardiac MR program with a special focus on pre-clinical and translational multi-modality imaging. He is also adjunct Professor at the Pontificia Universidad Católica de Chile both in the Institute for Biological and Medical Engineering and the Department of Electrical Engineering. Dr. Botnar is a Fellow of the International Society of Magnetic Resonance Imaging in Medicine and the Society for Cardiovascular Magnetic Resonance and co-chair of the ISMRM cardiac MR study group. He is an Associate Editor for the Journal of Cardiovascular Magnetic Resonance and Molecular Imaging and Biology and has published more than 325 peer-reviewed original and review articles and holds 12 patents related to MRI technology.
His main research interests include the development of novel MRI technologies for comprehensive and non-invasive assessment of heart disease. One particular focus of his work has been the development of radiation and contrast agent free coronary MR angiography. He is also actively pursuing the development and validation of novel molecular contrast agents (elastin, collagen, albumin, fibrin and MPO) for the detection of high-risk plaque and heart muscle disease using MRI, PET or PET-MR.